Hana Biosciences Inc·4

Feb 18, 6:02 PM ET

HAGEY ANNE E 4

4 · Hana Biosciences Inc · Filed Feb 18, 2010

Insider Transaction Report

Form 4
Period: 2010-02-16
HAGEY ANNE E
VP, Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2010-02-16+350,000350,000 total
    Exercise: $0.19Exp: 2020-02-16Common Stock (350,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $0.14Exp: 2019-02-24Common Stock (150,000 underlying)
    150,000
  • Stock Option (right to buy)

    Exercise: $1.04Exp: 2018-04-23Common Stock (200,000 underlying)
    200,000
Footnotes (3)
  • [F1]66,667 shares vest on each of 4/23/09 and 4/23/10; 66,666 shares vest on 4/23/11.
  • [F2]50,000 shares vest on each of 2/24/10, 2/24/11 and 2/24/12.
  • [F3]One-third of the shares vest on 2/16/11 and the remaining two-thirds vest in equal 24 monthly installments thereafter.

Documents

2 files
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY